Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 407, Issue 1-2, Pages 41-50Publisher
SPRINGER
DOI: 10.1007/s11010-015-2452-9
Keywords
Apigenin; Mesenchymal stem cell; Osteogenesis; Osteoporosis; JNK and p38 MAPK signaling pathway
Categories
Funding
- National Natural Science Foundation of China [30772768, 81102450]
- Science and Technology Planning Project of Guangdong Province [2013B03 1800013]
- Natural Science Foundation of Guangdong Province [2014A030313534]
- Science and Technology Planning Project for Medical Treatment and Public Health of Dongguan [2014105 101294]
- Initiating Fund of Scientific Research for Doctors of Guangdong Medical University [B2013016]
Ask authors/readers for more resources
Apigenin is a plant-derived flavonoid and has been reported to prevent bone loss in ovariectomized mice, but the role of apigenin on osteogenic differentiation of human mesenchymal stem cells (hMSCs) has not been reported. In the present study, the effect of apigenin on osteogenic differentiation of hMSCs was explored. Our results showed that apigenin treatment significantly increased alkaline phosphatase (ALP) activity and mineralization in hMSCs. RT-PCR revealed that apigenin markedly up-regulated the mRNA expression of osteopontin (OPN) and the transcription factors runt-related transcription factor 2 (Runx2). The expression of Runx2 and osterix (OSX) proteins were also increased in hMSCs differentiating into osteoblasts after treatment with apigenin. Furthermore, we investigated the signaling pathways responsible for osteogenic differentiation of apigenin in hMSCs. We found that apigenin treatment significantly increased the levels of p-JNK, p-p38 in hMSCs and addition of the inhibitors of JNK (SP600125) or p38 MAPK (SB203580) eliminated the stimulating effects of apigenin. In addition, addition of SP600125 or SB203580 also blocked apigenin-induced ALP activity, OPN, Runx2, and OSX expression and meanwhile inhibited bone nodule formation. Taken together, these findings suggest apigenin promotes the osteogenesis of hMSCs through activation of JNK and p38 MAPK signal pathways which leads to Runx2 and OSX expressions to induce the formation of bone nodule.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available